Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Human Reproductive Technology Products and Markets Analysis Report 2022: Data from 2020-2021, Estimates for 2022, and CAGR Projections through 2027

      Research_and_Markets_Logo

      News provided by

      Research and Markets

      Aug 26, 2022, 10:15 ET

      Share this article

      Share this article


      DUBLIN, Aug. 26, 2022 /PRNewswire/ -- The "Human Reproductive Technologies: Products and Global Markets" report has been added to ResearchAndMarkets.com's offering.

      Increasing investments and advancements in each of the three major areas of infertility, contraception, and sexual dysfunction.

      The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants, and investigates pipeline products and technologies.

      Many factors influence the human reproductive arena. Countries differ in their approaches and acceptance of fertility, contraception, and sexual dysfunction. Culture, religion, and social environment all play a role; depending on the country and position of women in the society, it can make a huge difference on how reproduction is treated.

      The choice of contraception varies by country: in Japan, condoms and abortions are preferred to other methods; in India, sterilization is the preferred method of birth control; in China, the use of the coil is preferred; while in Africa, injectable birth control dominates. This difference in preference by country is also seen in the fertility and sexual dysfunction areas.

      One of the most widely publicized, celebrated and, at the time, controversial medical landmarks in this area is the use of assisted reproductive technology (ART) to manage infertility. Recent developments in the field of ART have intensified the hopes and the wishes of infertile people to resolve their infertility, resulting in an increasing demand for such services in both developed and developing countries.

      While developments in ART have evolved rapidly, so have the ethical, social, and political controversies that surround nearly all aspects of ART. Few other areas in medicine have posed so many social and ethical questions and attracted so much public attention. Cultural differences influence the acceptance of ART.

      In addition, economic forces play a role in this market because it is an expensive undertaking that is not affordable to many. In Asia, the doors seem to be opening for growth, but there are barriers to overcome such as educating physicians and patients about the procedures and social and culture mores that influence ART.

      New developments in the area of contraception have stepped up the quest for easier, safer, and more convenient methods of contraception. There is no miracle drug or method of contraception, but scientists are pursuing several avenues of discovery to create better options for individuals.

      Sexual dysfunction is now an acknowledged disorder by the general public and the medical community. Prior to the advent of Viagra, the disorder was present but not acknowledged and largely went untreated. The introduction of Viagra opened Pandora's box in the development of sexual dysfunction drugs and devices for both sexes, at a time when female sexual dysfunction was virtually unknown.

      This area of reproductive health is teeming with opportunities for research and discovery and will likely continue to advance over the next few years, but progress has been slow, and some ED products are open to generic development.

      Descriptive company profiles of the leading global players, including Actavis,Inc., Bayer AG, EMD Serono,Inc. and Quidel Corp.

      Report Includes

      • Analyses of the global market trends, with data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
      • Evaluation and forecast the overall market size, projected growth trends, and corresponding market share analysis by treatment type, disease indication, end-user vertical, and geographic region
      • In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of this reproductive health market
      • Discussion of the emerging technology trends, opportunities and gaps in the market estimating current and future demand for reproductive drugs and technologies, and COVID-19 implications within the marketplace
      • Identification of promising new products and technologies still in the development and pipeline stage, and assess the probability that they will be commercialized successfully in the next five years
      • Review of the company competitive landscape for global human reproductive drugs market, their product portfolios, global rankings, and company value share analysis based on segmental revenues
      • Key merger and acquisition deals, new product launches, and other strategic alliances within the industry
      • A relevant patent analysis

      Key Topics Covered:

      Chapter 1 Introduction

      Chapter 2 Summary and Highlights

      Chapter 3 Industry Overview

      • Structure and Function of the Reproductive System
      • Male
      • Female
      • Neuroendocrine Regulation
      • Menarche
      • Menstruation Cycle
      • Phases of Sexual Responses
      • Male Sexual Response
      • Female Sexual Response
      • Neurohormonal Control of the Female and Male Reproductive System
      • Effects of Aging
      • Issues and Trends of Reproductive Health
      • Contraceptive Insurance
      • Over-The-Counter Birth Control Pills
      • Pre-Implantation Genetic Diagnosis
      • Designer Babies
      • New Use for Contraceptives
      • Aging and Infertility
      • Death by Contraceptive Patch
      • Sexual Dysfunction and Cancer
      • Infertility and Cancer
      • Signaling Pathway for Fertility Treatment
      • Marketing Tactics
      • Male Birth Control
      • Merchandising Targeting Women
      • Counterfeit Products
      • Surplus Embryos and Fetuses
      • Stem Cell and Other Controversial Issues - Selected International Views
      • Controversial Disposal of Embryos
      • Demographics

      Chapter 4 Infertility Market

      • Introduction and Overview of Infertility
      • Definition of Infertility
      • Etiology of Infertility
      • Evaluation of Fertility
      • Unexplained Infertility
      • Multiple Births
      • Asia Factor

      Chapter 5 Covid-19 Impact

      • Introduction
      • Covid-19: Impact on the Medical Devices and Pharma Industries
      • Decline/Delay in Elective Procedures
      • Covid-19 Impact on Supply Chain
      • U.S. Supply Chain: Covid-19 Impact
      • European Supply Chain: Covid-19 Impact
      • Apac Supply Chain: Covid-19 Impact
      • China: Covid-19 Impact
      • Covid-19 Impact on Medical Device and Pharmaceutical Product Segments
      • Covid-19 Impact on Critical Devices
      • Covid-19 Impact on Human Reproductive Technologies and Products Markets

      Chapter 6 Methods of Treatment

      • Fertility Pharmaceuticals
      • Introduction and Types
      • Market Revenues and Forecast
      • Future Advancements in Infertility Products
      • Competitive Analysis

      Chapter 7 Assistive Reproductive Technologies

      • Introduction
      • Types
      • Ivf
      • Ovulation Induction
      • Oocyte Retrieval
      • Intracytoplasmic Sperm Injection (Icsi)
      • Fertilization
      • Embryo Transfer
      • Results of Ivf
      • Gift
      • Zift
      • Wombs for Rent
      • Oocyte Donation
      • Frozen Embryos
      • United States Fertility Clinics
      • Market Revenues and Forecast
      • Future Trends in Assistive Reproductive Technology
      • Competitive Analysis Chapter 8 Fertility Diagnostics
      • Introduction
      • Types
      • Urine Studies
      • Market Revenues and Forecast
      • Competitive Analysis
      • Future Advancements in Diagnostic Fertility Treatment
      • Total Infertility Market Revenues and Forecast

      Chapter 9 Contraception Market

      • Introduction and Overview of Contraception
      • Pharmaceuticals
      • Types
      • Other Drug Regimens for Contraception
      • Market Revenues and Forecast
      • Competitive Analysis
      • Prescription Devices
      • Market Revenues and Forecast
      • Competitive Analysis
      • Future Advancements in Contraception
      • Total Market Revenues and Forecast

      Chapter 10 Sexual Dysfunction Market

      • Introduction and Overview
      • Types of Sexual Dysfunction
      • Causes of Sexual Dysfunction
      • Demographics of Sexual Dysfunction
      • Pharmaceuticals
      • Introduction and Types
      • Market Revenues and Forecast
      • Competitive Analysis
      • Devices
      • Market Revenues and Forecast
      • Future Advancements in Sexual Dysfunction
      • Total Market Revenues and Forecast

      Chapter 11 Patents

      • Patent Analysis by Manufacturer
      • Patent by Company
      • Patents by Application
      • Infertility Treatments
      • Contraception
      • Sexual Dysfunction
      • Leading Market Manufacturers

      Chapter 12 Total Market

      • Total Global Market for Reproductive Technologies and Products, by Region
      • North America
      • Europe
      • Asia-Pacific
      • Rest of the World
      • Total Market Size by Category
      • Industry Participants by Category
      • Total Market Size by Product Type

      Chapter 13 Competitive Landscape

      Chapter 14 Company Profiles

      • Actavis, Inc.
      • Bayer AG
      • Bristol-Myers Squibb Co.
      • Church & Dwight Company Inc.
      • Coopersurgical Inc.
      • Eli Lilly & Co.
      • Emd Serono, Inc.
      • Ferring Pharmaceuticals
      • GlaxoSmithKline plc
      • Janssen Pharmaceutical
      • Merck Inc.
      • Novartis International AG
      • Pfizer Inc.
      • Princeton Biomeditech Corp.
      • Quidel Corp.
      • Teva Pharmaceuticals.
      • Vivus Inc.

      For more information about this report visit https://www.researchandmarkets.com/r/3y9iat

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.